AI Patent Analysis Toolkit
PatentAgility
by KellDann

Examiner Dennis John Sullivan

Examiner Dennis John Sullivan appears to be about average relative to their peer examiners. Their lifetime grant ratio is 35.0%, they average 1.73 office actions per granted patent, and their rejection profile leans toward ยง103.

Difficulty vs AU About Average
Difficulty vs Group About Average
Difficulty vs TC About Average
Difficulty vs USPTO About Average
Average OA / Grant 1.73
Export
Word PDF

Create account to export.

Examiner Details

Observed Examiner Years
6 years (2021-2026)
Phone
(571) 272-0509
Predicted Supervisor
Samira Jean-Louis
Supervisor Phone
(571) 270-3503
Tech Center
1600 - Biotechnology and Organic
Group
1640 - Immunology

Metrics

Applications Evaluated
157
Granted Applications
55
Non-Granted Applications
102
Avg OA / Grant
1.73
Last OA Observed
June 2026 (1 months ago)
Art Units Seen
1642 , 1644
Work Groups Seen

Context Comparison

Scope Examiners Lifetime Grant Ratio Avg OA / Grant
This Examiner 1 35.0% 1.73
Art Unit 22 42.2% 1.94
Group 223 43.8% 1.94
Tech Center 1,365 38.5% 2.02
USPTO 16,347 53.5% 1.98

Grant Timeline

0.0% 25.0% 50.0% 75.0% 100.0% 2021 2022 2023 2024 2025 2026
Shaded region marks the last two observed years, where grant outcomes may lag due to recency.
Year Applications Granted Grant Rate
No observed data before 2021; examiner may not yet have been active in the available dataset.
2021 5 4 80.0%
2022 33 20 60.6%
2023 19 10 52.6%
2024 28 19 67.9%
2025 27 2 7.4%
2026 45 0 0.0%

55 family-cache-validated grants; 0 OA-only grant signals.

Rejection Timeline

OA # Office Actions § 101 Percentage § 102 Percentage § 103 Percentage § 112 Percentage
1 154 2.6% 1.9% 39.6% 10.4%
2 79 2.5% 0.0% 45.6% 10.1%
3 46 0.0% 0.0% 60.9% 10.9%
4 23 0.0% 0.0% 65.2% 8.7%
5 13 0.0% 0.0% 69.2% 7.7%
6 8 0.0% 0.0% 75.0% 12.5%
7 4 0.0% 0.0% 75.0% 0.0%

§ 101 Yearly Trend

2024: AI Examples
2025: Aug. Memo
0.0%
2020
23.1%
2021
3.1%
2022
0.0%
2023
0.0%
2024
0.0%
2025
2.0%
2026

Each bar shows the share of this examiner's observed office actions in that year that included a § 101 rejection.